As reported in Mergermarket’s Deal Dimensions series titled Life lines: Life sciences M&A and the rise of personalised medicine, 94 per cent of life sciences companies are planning an acquisition in the next year, with more than two-thirds (70 per cent) of respondents targeting personalised medicine.
Reed Smith will host a launch event regarding the report in their New York office on Tuesday, December 1st, from 12:00 PM ET – 1:00 PM ET. Report contributors including LSHI attorney Carol Loepere, Diane Frenier and Brian Miner will lead the informal, interactive discussion of the report’s findings over lunch. Discussion questions will include:
- What are the main drivers behind the sector’s pursuit for cross-border deals?
- What are the challenges faced in executing those deals?
- How may advances in personalized medicine change the face of the industry?
To register for the event, please click here.
